Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.
Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, Murali RV, Mukthey AB, Bhatt R, Chatterjee S, Rajan RE, Cheedarla N, Yadavalli VS, Mahadevan A, Shankar SK, Rajagopalan N, Shet A, Saravanan S, Balakrishnan P, Solomon S, Vajpayee M, Satish KS, Kundu TK, Jeang KT, Ranga U. Bachu M, et al. Among authors: cheedarla n. J Biol Chem. 2012 Dec 28;287(53):44714-35. doi: 10.1074/jbc.M112.397158. Epub 2012 Nov 6. J Biol Chem. 2012. PMID: 23132857 Free PMC article.
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
Munusamy Ponnan S, Swaminathan S, Tiruvengadam K, K K V, Cheedarla N, Nesakumar M, Kathirvel S, Goyal R, Singla N, Mukherjee J, Bergin P, T Kopycinski J, Gilmour J, Prasad Tripathy S, Luke HE. Munusamy Ponnan S, et al. Among authors: cheedarla n. PLoS One. 2018 Aug 29;13(8):e0203037. doi: 10.1371/journal.pone.0203037. eCollection 2018. PLoS One. 2018. PMID: 30157242 Free PMC article. Clinical Trial.
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations.
Selvavinayagam ST, Sankar S, Yong YK, Murugesan A, Suvaithenamudhan S, Hemashree K, Rajeshkumar M, Kumaresan A, Pandey RP, Shanmugam S, Arthydevi P, Kumar MS, Gopalan N, Kannan M, Cheedarla N, Tan HY, Zhang Y, Larsson M, Balakrishnan P, Velu V, Byrareddy SN, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: cheedarla n. medRxiv [Preprint]. 2024 Apr 19:2024.04.16.24305882. doi: 10.1101/2024.04.16.24305882. medRxiv. 2024. PMID: 38699322 Free PMC article. Preprint.
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
Selvavinayagam ST, Suvaithenamudhan S, Yong YK, Hemashree K, Rajeshkumar M, Kumaresan A, Arthydevi P, Kannan M, Gopalan N, Vignesh R, Murugesan A, Sivasankaran MP, Sankar S, Cheedarla N, Anshad AR, Govindaraj S, Zhang Y, Tan HY, Larsson M, Saravanan S, Balakrishnan P, Kulanthaivel L, Singh K, Joseph N, Velu V, Byrareddy SN, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: cheedarla n. J Med Virol. 2024 Feb;96(2):e29456. doi: 10.1002/jmv.29456. J Med Virol. 2024. PMID: 38329187
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers.
Cheedarla N, Verkerke HP, Potlapalli S, McLendon KB, Patel A, Frank F, O'Sick WH, Cheedarla S, Baugh TJ, Damhorst GL, Wu H, Graciaa D, Hudaib F, Alter DN, Bryksin J, Ortlund EA, Guarner J, Auld S, Shah S, Lam W, Mattoon D, Johnson JM, Wilson DH, Dhodapkar MV, Stowell SR, Neish AS, Roback JD. Cheedarla N, et al. iScience. 2023 Oct 18;26(11):108256. doi: 10.1016/j.isci.2023.108256. eCollection 2023 Nov 17. iScience. 2023. PMID: 37965140 Free PMC article.
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron.
Patel A, Kumar S, Lai L, Keen M, Valanparambil R, Chakravarthy C, Laughlin Z, Frank F, Cheedarla N, Verkerke HP, Neish AS, Roback JD, Davis CW, Wrammert J, Sharma A, Ahmed R, Suthar MS, Murali-Krishna K, Chandele A, Ortlund E. Patel A, et al. Among authors: cheedarla n. Cell Rep. 2023 Sep 26;42(9):113150. doi: 10.1016/j.celrep.2023.113150. Epub 2023 Sep 13. Cell Rep. 2023. PMID: 37708028 Free PMC article.
Characterization of the inflammatory response to COVID-19 illness in pregnancy.
Forrest AD, Poliektov NE, Easley KA, Michopoulos V, Ravi M, Cheedarla N, Neish AS, Cheedarla S, Roback JD, Dunlop AL, Badell ML, Dude CM. Forrest AD, et al. Among authors: cheedarla n. Cytokine. 2023 Oct;170:156319. doi: 10.1016/j.cyto.2023.156319. Epub 2023 Aug 4. Cytokine. 2023. PMID: 37544133
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment.
Faliti CE, Anam FA, Cheedarla N, Woodruff MC, Usman SY, Runnstrom MC, Van TTP, Kyu S, Ahmed H, Morrison-Porter A, Quehl H, Haddad NS, Chen W, Cheedarla S, Neish AS, Roback JD, Antia R, Khosroshahi A, Lee FE, Sanz I. Faliti CE, et al. Among authors: cheedarla n. medRxiv [Preprint]. 2023 Jun 12:2023.06.08.23291159. doi: 10.1101/2023.06.08.23291159. medRxiv. 2023. PMID: 37398319 Free PMC article. Preprint.
Blood group A enhances SARS-CoV-2 infection.
Wu SC, Arthur CM, Jan HM, Garcia-Beltran WF, Patel KR, Rathgeber MF, Verkerke HP, Cheedarla N, Jajosky RP, Paul A, Neish AS, Roback JD, Josephson CD, Wesemann DR, Kalman D, Rakoff-Nahoum S, Cummings RD, Stowell SR. Wu SC, et al. Among authors: cheedarla n. Blood. 2023 Aug 24;142(8):742-747. doi: 10.1182/blood.2022018903. Blood. 2023. PMID: 37367252 Free PMC article.
35 results